Change in weight (kg) · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in height · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in quality of life · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Participants with Crohn's disease in remission
Elemental formula supplements showed no clear difference in withdrawals due to adverse events compared with polymeric formula supplements (low certainty).
1 finding from 1 review
Relapse · Participants with Crohn's disease in remission
It is very uncertain whether elemental formula supplements changes relapse compared with no supplementation (very low certainty).
1 finding from 1 review
Change in weight (kg) · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Length of Survival · people with advanced cancer with inoperable malignant bowel obstruction (MBO)
1 finding from 1 review
Intervention not reported
Quality of life · people with advanced cancer with inoperable malignant bowel obstruction (MBO)
1 finding from 1 review
Intervention not reported
Adverse events · people with advanced cancer with inoperable malignant bowel obstruction (MBO)
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
It is very uncertain whether probiotics changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
It is very uncertain whether probiotics changes systemic inflammatory response syndrome compared with control (very low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
It is very uncertain whether probiotics changes organ failure compared with control (very low certainty).
1 finding from 1 review
Adverse events · patients with acute pancreatitis
Probiotics showed no clear difference in adverse events compared with control (low certainty).
1 finding from 1 review
Serious adverse events · patients with acute pancreatitis
It is very uncertain whether probiotics changes serious adverse events compared with control (very low certainty).
1 finding from 1 review